Company
Galderma Labs Lp
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
27
20 still marketed
Novel approvals
4
Approvals since 2021
3
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Differin Epiduo Acne Gel (Adapalene and Benzoyl Peroxide) approved May 22, 2026
- Nemluvio approved NovelDec 13, 2024
- Nemluvio approved NovelBreakthrough therapyPriority reviewAug 12, 2024
- Vectical new use Jul 17, 2020
- Aklief approved NovelOct 4, 2019
- Differin new use Jul 8, 2016
- Epiduo Forte approved Jul 15, 2015
- Soolantra approved Dec 19, 2014
- Mirvaso approved Aug 23, 2013
- Epiduo new use Feb 1, 2013
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (20)
Newest FDA action first.
- Differin Epiduo Acne Gel (Adapalene and Benzoyl Peroxide) Adapalene, Benzoyl Peroxide, Adapalene, Benzoyl Peroxide · 2026
- Nemluvio Nemolizumab-Ilto · 2024
- Nemluvio Nemolizumab-Ilto · 2024
- Oracea Doxycycline · 2006
- Differin Adapalene · 2007
- Metrogel Metronidazole · 2005
- Soolantra Ivermectin · 2014
- Aklief Trifarotene · 2019
- Differin Adapalene · 1996
- Epiduo Forte Adapalene, Benzoyl Peroxide · 2015
- Vectical Calcitriol · 2009
- Clobex Clobetasol Propionate · 2005
- Mirvaso Brimonidine Tartrate · 2013
- Tri-Luma Fluocinolone Acetonide, Hydroquinone, Tretinoin · 2002
- Metrolotion Metronidazole · 1998
- Differin Adapalene · 2000
- Desowen Desonide · 1984
- Clobex Clobetasol Propionate · 2003
- Clobex Clobetasol Propionate · 2004
- Metrocream Metronidazole · 1995
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.